Skip to content
Screener

NeoGenomics NEO Pre-Tax Income

Pre-Tax Income at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
-$34.1M-16.0%
Quest Diagnostics logo
Quest DiagnosticsDGX
$412M+7.3%
Personalis, Inc. logo
Personalis, Inc.PSNL
-$30.02M-90.7%
Guardant Health logo
Guardant HealthGH
-$111.7M-17.7%
Natera, Inc. logo
Natera, Inc.NTRA
-$67.23M+33.2%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
-$25.98M-122%

Segments

By segment

See full
Reportable Segment$1.83M+104%

Other financials

Income statement

See full
Revenue$201.7M+11.2%
Gross profit$91.9M+18.9%
Operating income-$9.8M+79.5%
Net income$2.2M+105%
EPS (diluted)$0.02+106%

Balance sheet

See full
Cash & equivalents$145.5M-5.9%
Total debt$448.4M+534%
Total equity$785.7M-8.0%
Total assets$1.4B-3.0%

Cash flow

See full
Operating cash flow$20.0M-1.8%
CapEx$8.2M+30.0%
Free cash flow-$13.1M+56.0%

Valuation

See full
Market cap$2B+182%
Enterprise value$2.3B+268%
P/S2.6×+1.6×

Profitability

See full
Gross margin43.9%0.0pp
Operating margin-8.9%-2.8pp
Net margin-6.8%-2.4pp
FCF margin-4.9%

Returns & leverage

See full
Return on equity-6.3%-2.0pp
Debt / equity0.6×+0.5×
Current ratio3.6×-0.3×

Where this comes from

Reported directly by NeoGenomics in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.

The source filing: NeoGenomics’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 4:09 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001077183-26-000059
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Interest expense(781)(933)(1,379)(2,551)
Other (expense) income, net(17)482(29)547
Gain on extinguishment of debt (Note 6)11,18111,181
Income (loss) before taxes1,826(45,816)(15,752)(71,473)
Income tax benefit412724884458
NET INCOME (LOSS)$2,238$(45,092)$(14,868)$(71,015)
NET INCOME (LOSS) PER SHARE
Basic$0.02$(0.35)$(0.11)$(0.56)

Item 1. Financial Statements (unaudited)

FAQ

What is NeoGenomics's pre-tax income?
NeoGenomics (NEO) reported pre-tax income of $1.83M in Q2 2026.
How has NeoGenomics's pre-tax income changed year-over-year?
NeoGenomics's pre-tax income increased by 104.0% year-over-year, from -$45.82M to $1.83M.
What is the long-term trend for NeoGenomics's pre-tax income?
Over 4 years (2021 to 2025), NeoGenomics's pre-tax income has grown at a 64.5% compound annual growth rate (CAGR), from -$15.08M to -$110.27M.
What does pre-tax income mean?
Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.

Ask your AI about NeoGenomics's pre-tax income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude